Ushur, a leader in AI-powered customer experience automation (CXA), has announced the launch of its new solution, UshurX, which is designed to streamline time-intensive tasks during clinical trials.
The launch of UshurX was driven by the need to address inefficiencies in clinical trials, particularly in the areas of recruitment, enrolment, and retention.
With recruitment being the largest cost factor in clinical trials, accounting for 32% of total costs, and 37% of trial sites failing to meet enrolment targets, Ushur aims to reduce delays that can cost up to $8m per day in lost revenue.
Ushur’s core offering is its AI-powered enterprise experience automation platform, which enables digital engagement across multiple sectors, including life sciences, healthcare, and insurance.
The company’s solutions help organisations improve operational efficiency, reduce costs, and enhance customer experiences.
The new UshurX solution provides a comprehensive digital engagement platform for clinical trials, allowing biopharma and life sciences companies to automate key tasks.
These include dynamic pre-screening questionnaires, participant onboarding, and continuous monitoring throughout the clinical trial process. UshurX delivers these services through participants’ preferred communication channels, such as messaging and emails.
One of the standout features of UshurX is its HIPAA-compliant security framework, ensuring that protected health information (PHI) remains secure.
Additionally, the platform offers native e-signature and ADA-compliant accessibility features, enabling a more streamlined and inclusive user experience. The system is also powered by generative AI, utilising healthcare-specific, industry-safe large language models (LLMs) to enhance engagement.
Other key features of UshurX include its modular design, which allows biopharma and life sciences companies to customise the platform to meet the unique needs of each trial.
This ensures faster time-to-value and reduced trial durations, while also helping organisations boost participant retention and reduce costs.
Yvonne Daugherty, Global Head of Industries at Ushur, said, “Biopharma and Life Sciences companies are faced with strict regulations and resulting organizational silos. Ushur’s digital engagement solution not only reduces the cost of running clinical trials, but also boosts recruitment and retention across diverse populations. We’re making modernisation as easy as possible with modular experiences for the most impactful journey steps, easily customizable to each trial’s unique needs. This launch underscores Ushur’s mission to improve the global healthcare system and make quality care accessible for all.”
By adopting UshurX, biopharma and life sciences companies can improve enrolment and retention rates by 25%, cut trial durations by 15-20%, and reduce costs per patient by 20-30%, accelerating their time-to-market.
For more information on the offering, click here.
Keep up with all the latest FinTech news here
Copyright © 2024 FinTech Global
